Mycobacterium bovis BCG-Mediated Protection against W-Beijing Strains of Mycobacterium tuberculosis Is Diminished Concomitant with the Emergence of Regulatory T Cells

Despite issues relating to variable efficacy in the past, the Mycobacterium bovis BCG vaccine remains the basis for new-generation recombinant vaccines currently in clinical trials. To date, vaccines have been tested mostly against laboratory strains and not against the newly emerging clinical strai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ordway, Diane J., Shang, Shaobin, Henao-Tamayo, Marcela, Obregon-Henao, Andres, Nold, Laura, Caraway, Megan, Shanley, Crystal A., Basaraba, Randall J., Duncan, Colleen G., Orme, Ian M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165219/
https://ncbi.nlm.nih.gov/pubmed/21795460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05127-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados